2025-524385-18-00招募中4 期
A Randomised, Open-Label, Single-Centre, Study to Evaluate the Bioequivalence of Lanifibranor
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- Inventiva
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Medical Director
Scientific
Inventiva
研究点 (1)
Loading locations...
相似试验
已完成
Unknown
A Clinical Study to check the safety and effectiveness of AVL200 Modular Intraocular Lens.CTRI/2023/05/052664ATIA VISION,INC100
进行中（未招募）
不适用
A multicenter, open-label, single-arm study with regard to the efficacy of 10-hydroxy-cis-12-octadecenoic acid on insulin sensitivity in patients with impaired glucose tolerance and mild diabetes mellitusPatients with impaired glucose tolerance or patients with diabetesJPRN-jRCTs051200080Ogawa Wataru45
进行中（未招募）
不适用
A multicenter, open-label, single-arm study with regard to the efficacy of 10-hydroxy-cis-12-octadecenoic acid on insulin sensitivity in patients with impaired glucose tolerance and mild diabetes mellitusjRCTs05120008045
进行中（未招募）
不适用
Clinical study to compare the safety and immune response of HEPLISAV™ to Engerix-B® and Fendrix® in Adults on Hemodialysis who were previously vaccinated without success.EUCTR2010-019633-10-DEDynavax Technologies Corporation150
尚未招募
不适用
A single-center, prospective, open-label study investigating the effect of Ninjin'yoeito on frailty in hemodialysis patients.frailty in hemodialysis patientsJPRN-UMIN000052058Japanese Red Cross Kumamoto Hospital40